Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Optic Neuritis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Myelitis, Transverse 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Cerebellar Diseases 1Burkitt Lymphoma 1

Interventions

eculizumab 3ublituximab 1ravulizumab 1Sugars 1Rituximab 1Plasma Exchange 1OM 89 1N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide 1Mitoxantrone 1LFB-R603 1Interferon beta-1a 1Immunoglobulins, Intravenous 1Blood Specimen Collection 1Adrenal Cortex Hormones 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelitis, Transverse × Interferon beta-1a × Clear all
NCT00179478 2017-09-06

CHAMPIONS10

Beth Israel Deaconess Medical Center

Phase 4 Completed
155 enrolled 10 charts

Cerebellar Diseases, Multiple Sclerosis, Myelitis, Transverse, Optic Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡